Tuhura Biosciences Inc (HURA)

Dec 11, 2025

TuHURA Biosciences provides corporate update after $15.6M financing By Investing.com - Investing.com South Africa

Dec 11, 2025

Dec 11, 2025

TuHURA Biosciences (NASDAQ: HURA) outlines 2026 trial milestones after $15.6M raise - Stock Titan

Dec 11, 2025

Dec 10, 2025

TuHURA Biosciences Announces Securities Purchase Agreement - TipRanks

Dec 10, 2025

Dec 09, 2025

Big Drops For Top Wealth, TuHURA Biosciences, And AutoZone - Finimize

Dec 09, 2025

Dec 09, 2025

Top US Stock Market Losers Today (December 9, 2025): HURA, Phreesia, Virgin Galactic, SLM, Gogo and More - ts2.tech

Dec 09, 2025

Dec 09, 2025

TuHURA Biosciences announces $15.6M registered direct offering - TipRanks

Dec 09, 2025

Dec 09, 2025

TuHURA Biosciences plunges after $15.6 million direct stock deal - TradingView

Dec 09, 2025

Dec 09, 2025

TuHURA Biosciences announces $15.6 million registered direct offering - Investing.com

Dec 09, 2025

Dec 09, 2025

TuHURA Biosciences announces $15.6 million registered direct offering By Investing.com - Investing.com Nigeria

Dec 09, 2025

Dec 09, 2025

TuHURA Biosciences, Inc. Announces $15.6 Million Registered Direct Offering - PR Newswire

Dec 09, 2025

Dec 08, 2025

Liminatus Pharma (LIMN) Competitors and Alternatives 2025 - MarketBeat

Dec 08, 2025

Dec 08, 2025

TuHURA Biosciences Presents Data Demonstrating the Delta Opioid Receptor as A New Target in Overcoming Acquired Resistance to Immune Checkpoint Inhibitors At the 57Th Annual Meeting and Exposition - marketscreener.com

Dec 08, 2025

Dec 08, 2025

TuHURA Biosciences presents research on potential role of DOR at ASH - TipRanks

Dec 08, 2025

Dec 08, 2025

TuHURA Biosciences presents data on DOR’s role in cancer immunotherapy By Investing.com - Investing.com South Africa

Dec 08, 2025

Dec 08, 2025

TuHURA Biosciences presents data on DOR’s role in cancer immunotherapy - Investing.com

Dec 08, 2025

Dec 08, 2025

TuHURA Biosciences Presents Data Demonstrating the Delta Opioid Receptor (DOR) as a New Target in Overcoming Acquired Resistance to Immune Checkpoint Inhibitors at the 57th ASH Annual Meeting and Exposition - PR Newswire

Dec 08, 2025

Dec 07, 2025

Tuhura Biosciences amends loan agreement, secures full $3M - MSN

Dec 07, 2025

Dec 06, 2025

TuHURA Biosciences (HURA) Stock Analysis Report | Financials & Insights - Benzinga

Dec 06, 2025

Dec 06, 2025

TuHURA Biosciences (NASDAQ:HURA) Rating Increased to Hold at Wall Street Zen - MarketBeat

Dec 06, 2025

Dec 05, 2025

TuHURA Biosciences Amends Loan Agreement, Secures Full $3M - TipRanks

Dec 05, 2025

Dec 05, 2025

Can TuHURA Biosciences Inc. (PL3) stock deliver double digit returnsJuly 2025 Technicals & Verified Swing Trading Watchlists - Newser

Dec 05, 2025

Dec 05, 2025

What drives TuHURA Biosciences Inc stock pricePortfolio Diversification Tips & Superior Capital Growth - earlytimes.in

Dec 05, 2025

Dec 04, 2025

Will TuHURA Biosciences Inc. (PL3) stock deliver compounding returnsMarket Performance Summary & Fast Moving Stock Watchlists - Newser

Dec 04, 2025

Dec 04, 2025

Will TuHURA Biosciences Inc. stock reach all time highs in 2025July 2025 Opening Moves & Intraday High Probability Alerts - Newser

Dec 04, 2025

Dec 04, 2025

Is TuHURA Biosciences Inc. (PL3) stock a buy during volatile markets2025 Analyst Calls & Consistent Profit Trade Alerts - Newser

Dec 04, 2025

Dec 04, 2025

Can TuHURA Biosciences Inc. (PL3) stock sustain revenue momentumCPI Data & Free Community Supported Trade Ideas - Newser

Dec 04, 2025

Dec 02, 2025

Why TuHURA Biosciences Inc. (PL3) stock benefits from AI revolutionMarket Performance Summary & Proven Capital Preservation Tips - Newser

Dec 02, 2025

Dec 02, 2025

Can TuHURA Biosciences Inc. (PL3) stock beat analyst consensusEarnings Overview Summary & Stock Portfolio Risk Management - Newser

Dec 02, 2025

Nov 28, 2025

Stock Market Recap: Can TuHURA Biosciences Inc. stock weather global recessionEntry Point & Fast Gain Stock Trading Tips - moha.gov.vn

Nov 28, 2025

Nov 27, 2025

Top investors say TuHURA Biosciences Inc (HURA) ticks everything they need - Setenews

Nov 27, 2025

Nov 25, 2025

TuHURA Biosciences shelf registration statement becomes effective By Investing.com - Investing.com Australia

Nov 25, 2025

Nov 25, 2025

TuHURA Biosciences’ Shelf Registration Statement Effective - TipRanks

Nov 25, 2025

Nov 25, 2025

TuHURA Biosciences shelf registration statement becomes effective - Investing.com

Nov 25, 2025

Nov 25, 2025

TuHURA Biosciences Announces Effective Shelf Registration Statement - TradingView

Nov 25, 2025

Nov 22, 2025

TuHURA Biosciences (NASDAQ:HURA) Downgraded to Sell Rating by Wall Street Zen - Defense World

Nov 22, 2025

Nov 22, 2025

Equities Analysts Offer Predictions for HURA FY2025 Earnings - MarketBeat

Nov 22, 2025

Nov 21, 2025

TuHURA Biosciences, Inc. (NASDAQ:HURA) Receives Average Rating of "Buy" from Brokerages - MarketBeat

Nov 21, 2025

Nov 21, 2025

Zacks Small Cap Issues Optimistic Forecast for HURA Earnings - Defense World

Nov 21, 2025

Nov 21, 2025

TuHURA Biosciences, Inc. (NASDAQ:HURA) Receives Average Rating of “Buy” from Brokerages - Defense World

Nov 21, 2025

Nov 20, 2025

How TuHURA Biosciences Inc. stock performs in weak economyJuly 2025 Momentum & Fast Entry High Yield Stock Tips - newser.com

Nov 20, 2025

Nov 20, 2025

Is TuHURA Biosciences Inc. stock safe for conservative investorsJuly 2025 Update & Short-Term Trading Opportunity Alerts - newser.com

Nov 20, 2025

Nov 20, 2025

Can TuHURA Biosciences Inc. (PL3) stock hit consensus price targets2025 Performance Recap & Technical Pattern Based Signals - newser.com

Nov 20, 2025

Nov 20, 2025

Why TuHURA Biosciences Inc. stock is trending among retail tradersJuly 2025 Outlook & Safe Capital Preservation Plans - newser.com

Nov 20, 2025

Nov 19, 2025

Is it too late to sell TuHURA Biosciences Inc.2025 Big Picture & Weekly High Return Opportunities - newser.com

Nov 19, 2025